VRTX Vertex Pharmaceuticals
- 455.310
- +1.760+0.39%
- 455.310
- 0.0000.00%
Vertex Pharmaceuticals News
Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Biller Jonathan
Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer LEIDEN JEFFREY M
Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Bhatia Sangeeta N.
Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Vertex Pharmaceuticals | 8-K: Current report
Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Bhatia Sangeeta N.
Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bozic Carmen
Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SACHS BRUCE I
Vertex Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kewalramani Reshma
Vertex Pharmaceuticals | 8-K: Vertex Reports Second Quarter 2024 Financial Results
Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bozic Carmen
Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kewalramani Reshma
Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Analysis
Price Target
No Data
No Data
